Annual report
5199.TEDINET S100W2HG
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 146
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥209m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥440m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥171m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥382m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥730m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥486m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥227m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥383m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥376m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥298m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥143m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥170m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥298m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥11.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥634m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥211m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥772m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥706m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥278m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥123m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥152m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥111m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥282m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥347m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥676m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥803m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥450m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥235.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.42 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.89 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-112.56 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.03 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,209.1 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,042.65 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,820.6 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,442.65 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.82 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 36.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.6% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 250 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 278 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 276 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 287 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 285 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥7.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥7.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥8.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥204m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥426m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥167m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥370m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥714m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥496m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥379m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥363m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥297m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥283m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥504m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥167m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥160m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥11.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥11.4bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.7bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥234.59 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥223.35 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.23 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-131.92 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥125.82 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥78 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,091.45 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,964.09 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,760.74 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,388.09 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,575.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,286,199 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,286,199 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 245 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 272 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 272 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 281 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 279 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥6m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥16m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥455m |
| Medical Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥43m |
| Medical Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥104m |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 87 pure |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-03-31 | ¥3.5bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥8m |
| Precision Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥77m |
| Precision Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥141m |
| Precision Equipmentreportable segment | employees | at 2025-03-31 | 121 pure |
| Precision Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | segment assets | at 2025-03-31 | ¥3.6bn |
| Precision Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥710m |
| SP Divisionreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥24,000 |
| SP Divisionreportable segment | employees | at 2025-03-31 | 1 pure |
| SP Divisionreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥390m |
| SP Divisionreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥390m |
| SP Divisionreportable segment | segment assets | at 2025-03-31 | ¥84m |
| SP Divisionreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥23m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥217m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥271m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥664m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥21m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥23m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥467m |
| Medical Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥24m |
| Medical Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥111m |
| Medical Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| Medical Equipmentreportable segment | segment assets | at 2024-03-31 | ¥3.8bn |
| Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥9m |
| Precision Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥65m |
| Precision Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥159m |
| Precision Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Precision Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Precision Equipmentreportable segment | segment assets | at 2024-03-31 | ¥4.1bn |
| Precision Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥831m |
| SP Divisionreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥33,000 |
| SP Divisionreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥735m |
| SP Divisionreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥735m |
| SP Divisionreportable segment | segment assets | at 2024-03-31 | ¥230m |
| SP Divisionreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥36m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥90m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥290m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥906m |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 86 pure |
| Precision Equipmentreportable segment | employees | at 2025-03-31 | 117 pure |
| SP Divisionreportable segment | employees | at 2025-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,640
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row2Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row3Member | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding revaluation of land for business (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding extra retirement payments (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes derivatives consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |